Mississippi's GOP governor explains why herd immunity is just not 'a realistic solution' for COVID-19


For people who believe trying to contain COVID-19 is too hard, or not worth the socioeconomic tradeoffs, or too uncomfortable, letting the new coronavirus spread freely throughout the population to achieve herd immunity — the point where the virus has saturated a community enough that it is effectively contained — without waiting for a vaccine might sound like a tempting, viable alternative to masks, social distancing, and more stringent measures.
Mississippi Gov. Tate Reeves (R) disagrees, and he explained why with some back-of-the-envelope math in a Twitter thread Monday evening.
In Mississippi, 40 percent of the population would equal 1.2 million people getting infected, versus the 36,680 cases that have already left the state's hospitals "stressed to the point of pain," Reeves wrote. To put it another way, Mississippi would need at least 3,187 new COVID-19 cases every day for a year, triple the state's worst days of this pandemic.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And even if you were willing to stomach 1.2 million to 2.4 million Mississippi residents getting infected with the virus, a study from King's College in London released Monday suggested people may lose their COVID-19 immunity within months, making herd immunity moot.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Democrats: The 2028 race has begun
Feature Democratic primaries have already kicked off in South Carolina
-
The Pentagon's missing missiles
Feature The U.S. military is low on weapons. Can it restock before a major conflict breaks out?
-
Rescissions: Trump's push to control federal spending
Feature The GOP passed a bill to reduce funding for PBS, NPR and other public media stations
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths